Epinephrine auto-injectors are used to treat life-threatening allergic reactions in children and adults.
Sanofi, one of the largest makers of epinephrine auto-injectors, has issued a recall on all Auvi-Q® products currently on the market, including both 0.15 mg and 0.3 mg strengths. They have been found to potentially deliver the wrong dosage.
Sanofi has received 26 reports of suspected device malfunctions in the US and Canada as of October 26. Patients have described symptoms of underlying hypersensitivity reaction, but no fatalities have been reported to date.
For more information on this recall go to Auvi‑Q.com or call 1‑877‑319‑8963 or 1‑866‑726‑6340. Sanofi will provide reimbursement for out of pocket costs incurred for the purchase of new epinephrine auto‑injectors with proof of purchase.
Contact your doctor to obtain a prescription for an alternate Epi-Pen as soon as possible!
Want more great content from The Mother List? Sign up here!
